Web alert. Oligonucleotide, antibody and peptide therapeutics.
Stephens
Alick C
AC
Academic Department of Paediatrics, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London, W2 1PG, UK. a.stephens@imperial.ac.uk
D000911:Antibodies, Monoclonal / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000494:pharmacology; D016375:Antisense Elements (Genetics) / Q000627:therapeutic use; D006801:Humans; D009841:Oligonucleotides / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D010455:Peptides / Q000191:economics / Q000627:therapeutic use*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D016375:Antisense Elements (Genetics); D009841:Oligonucleotides; D010455:Peptides; D000069283:Rituximab